Close Menu

More articles about Disease Areas

People Transfer: Mar 11, 2009

Premium

ASU Biodesign Institute names Alan Nelson as institute director, and Joshua LaBaer as head of institute's Piper Center for Personalized Diagnostics

The Xpert MRSA/SA Blood Culture test is Cepheid's sixth test to receive a license from Health Canada.

Gentel and Eprogen will combine their respective technologies to make whole proteome microarrays for identifying new autoantibody biomarkers.

During the firm's earnings call last week, CEO Amit Kumar said that the company's diagnostics services performance would be most indicative of how CombiMatrix would perform going forward.

Researchers in the Neuromuscular Disorder-Chip Consortium will use custom-designed NimbleGen Human CGH 12x135K microarrays and Human Sequence Capture 385K arrays to study the genetic underpinnings of a range of neuromuscular disorders.

Funding Update for Mar 10, 2009

Premium

NIH Array-Related Grants Awarded Dec. 23, 2008 — March 10, 2009

The partners are deciding whether to run the multiplex test on a microarray or a sequencing platform. Factors in the decision include the complexity of the test and the technical feasibility of multiplexed, targeted resequencing.

Maybe more important than the gene they discovered, which only explains a fraction of inherited pancreatic cancers, is the sequencing-based approach the researchers took to pinpoint it.

IP Roundup: Mar 10, 2009

Premium

Accelr8, Whitehead Institute for Biomedical Research, Dana-Farber Cancer Institute, Stanford University, Aperio Technologies

BioArray Briefs: Mar 10, 2009

Premium

SeqWright, Mount Sinai Services, SQI Diagnostics, Tecan, GE Healthcare

The nine interdisciplinary cancer research centers will integrate computational and systems biology approaches.

Chronix Biomedical said that the current study confirms its previous research showing that CNAs can identify the presence of certain diseases in blood samples months to years before clinical symptoms appear.

Papers of Note: Mar 10, 2009

Premium

Sequencing-Related Papers of Note, Feb. 2009

Short Reads: Mar 10, 2009

Premium

Applied Biosystems, Translational Genomics Research Institute, National Center for Genome Resources, Kognitio, University of Cambridge, Genomatix, LabCorp, Duke University, DNAPrint Genomics

New Products: Mar 10, 2009

Premium

DNAStar ArrayStar v.3.0, SoftGenetics Mutation Surveyor, COSMIC v. 41

The firm published data from a study showing that the same biomarker used in its miRNA-based test for squamous lung cancer provided 96 percent sensitivity.

A European research team has developed an approach that uses information about positional weight matrices, comparative genomics, and gene expression profiling to find Stat3 transcription factor binding sites in the mouse genome.

The university will use the system in its stem cell and leukemia proteomics studies.

Applied Biosystems and TGen will collaborate on translational genomic disease studies employing the SOLiD 3 system. The partners also hope to drive down the cost of genome sequencing so that it can ultimately be used as a routine diagnostic tool.

Under terms of the deal, Novartis will give Epistem a $4 million upfront payment and provide funding to study the stem cell shop's drug targets. Epistem could also get up to $45 million in milestone payments for each product developed from targets licensed under the agreement.

Pages

Public health experts call for a transparent COVID-19 vaccine approval process in a letter; the Food and Drug Administration commissioner assures science-based approval.

The Verge reports that new gene-naming guidelines aim in part to avoid Excel-related name change confusion.

In Nature this week: tuatara genome sequence aids in understanding amniote evolution, and more.

According to the Guardian, UK virologists say in a letter to officials that their expertise has been pushed aside in COVID-19 response plans.